noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Synaptics Incorporated

Synaptics to Release Fourth Quarter and Full Year Fiscal 2026 Results[...]
Startengine Crowdfunding Inc.

Amendment to Offering Statement under Regulation A (Form 1-A/A)
City of North Port, FL

City to host Fire Safety 101 webinar on July 31

Healthcare

Alamar Biosciences Inc.

07/15/2026 | Press release | Distributed by Public on 07/15/2026 14:04

Material Event (Form 8-K)

Item 8.01

Other Events.

Alamar Biosciences, Inc. (the "Company") is deeply saddened to report that Ian Ratcliffe, a member of the Company's board of directors (the "Board"), passed away on July 5, 2026. The Company's management and Board extend their sincerest condolences to Mr. Ratcliffe's family. Mr. Ratcliffe served as an independent director on the Board since February 2024. The Company is extremely grateful for Mr. Ratcliffe's dedication and service to the Company.

Following Mr. Ratcliffe's passing, the Board decreased the number of authorized directors constituting the full Board to five and appointed Nicholas Naclerio, Ph.D., to the Audit Committee of the Board.

Alamar Biosciences Inc. published this content on July 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 15, 2026 at 20:04 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]